- Home
- APVO vs AMIX Comparison
APVO vs AMIX Comparison
Compare APVO & AMIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APVO
- AMIX
- Stock Information
- Founded
- APVO 2016
- AMIX 2014
- Country
- APVO United States
- AMIX United States
- Employees
- APVO N/A
- AMIX N/A
- Industry
- APVO Biotechnology: Pharmaceutical Preparations
- AMIX
- Sector
- APVO Health Care
- AMIX
- Exchange
- APVO Nasdaq
- AMIX NYSE
- Market Cap
- APVO 4.1M
- AMIX 3.5M
- IPO Year
- APVO N/A
- AMIX N/A
- Fundamental
- Price
- APVO $3.23
- AMIX $1.25
- Analyst Decision
- APVO Strong Buy
- AMIX Strong Buy
- Analyst Count
- APVO 1
- AMIX 1
- Target Price
- APVO $5,920.00
- AMIX $5.00
- AVG Volume (30 Days)
- APVO 6.7M
- AMIX 2.5M
- Earning Date
- APVO 08-07-2025
- AMIX 08-12-2025
- Dividend Yield
- APVO N/A
- AMIX N/A
- EPS Growth
- APVO N/A
- AMIX N/A
- EPS
- APVO N/A
- AMIX N/A
- Revenue
- APVO N/A
- AMIX N/A
- Revenue This Year
- APVO N/A
- AMIX N/A
- Revenue Next Year
- APVO N/A
- AMIX N/A
- P/E Ratio
- APVO N/A
- AMIX N/A
- Revenue Growth
- APVO N/A
- AMIX N/A
- 52 Week Low
- APVO $2.81
- AMIX $1.14
- 52 Week High
- APVO $485.37
- AMIX $42.40
- Technical
- Relative Strength Index (RSI)
- APVO 34.28
- AMIX 35.38
- Support Level
- APVO $2.81
- AMIX $1.14
- Resistance Level
- APVO $13.11
- AMIX $1.36
- Average True Range (ATR)
- APVO 1.10
- AMIX 0.10
- MACD
- APVO 0.30
- AMIX 0.00
- Stochastic Oscillator
- APVO 4.08
- AMIX 26.83
About APVO Aptevo Therapeutics Inc.
Aptevo Therapeutics Inc is a clinical-stage research and development biotechnology company focused on developing novel immunotherapeutic candidates for the treatment of different forms of cancer. Its clinical candidates are; ALG.APV-527, which targets co-stimulatory receptors and tumor antigens, and CD3xCD123, which is being developed as a potential treatment of frontline acute myelogenous leukemia. The company's preclinical candidates, APVO711, APVO0442, and APVO603, are being developed using the ADAPTIR modular protein technology platform. The company's versatile and robust ADAPTIR and ADAPTIR-FLEX platforms are designed to generate monospecific, bispecific, and multi-specific antibody candidates that are capable of enhancing the human immune system against cancer cells.
About AMIX AUTONOMIX MEDICAL INC
Autonomix Medical Inc is a development-stage medical device development company focused on advancing technologies for sensing and treating disorders relating to the nervous system. Its first-in-class technology platform includes a catheter-based microchip-enabled array that can detect and differentiate neural signals with a high degree of sensitivity as demonstrated in animal studies.